Literature DB >> 30918350

Gut microbial short-chain fatty acids and the risk of diabetes.

Wei Ling Lau1, Nosratola D Vaziri2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30918350     DOI： 10.1038/s41581-019-0142-7

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  11 in total

1.  Galangin Protects against Symptoms of Dextran Sodium Sulfate-induced Acute Colitis by Activating Autophagy and Modulating the Gut Microbiota.

Authors:  Hongzhuan Xuan; Aiqun Ou; Shengyu Hao; Jiajun Shi; Xiaolu Jin
Journal:  Nutrients       Date:  2020-01-29       Impact factor: 5.717

2.  Chronic exposure to ambient particulate matter induces gut microbial dysbiosis in a rat COPD model.

Authors:  Naijian Li; Zhaowei Yang; Baoling Liao; Tianhui Pan; Jinding Pu; Binwei Hao; Zhenli Fu; Weitao Cao; Yuming Zhou; Fang He; Bing Li; Pixin Ran
Journal:  Respir Res       Date:  2020-10-19

Review 3.  Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.

Authors:  Iwona Filipska; Agata Winiarska; Monika Knysak; Tomasz Stompór
Journal:  Toxins (Basel)       Date:  2021-04-10       Impact factor: 4.546

4.  Association between antibiotics use and diabetes incidence in a nationally representative retrospective cohort among Koreans.

Authors:  Sun Jae Park; Young Jun Park; Jooyoung Chang; Seulggie Choi; Gyeongsil Lee; Joung Sik Son; Kyae Hyung Kim; Yun Hwan Oh; Sang Min Park
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379

Review 5.  The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease.

Authors:  Yinghui Huang; Wang Xin; Jiachuan Xiong; Mengying Yao; Bo Zhang; Jinghong Zhao
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

6.  Association between gut microbiota and prediabetes in people living with HIV.

Authors:  Kulapong Jayanama; Angsana Phuphuakrat; Pisut Pongchaikul; Pinidphon Prombutara; Hataikarn Nimitphong; Sirimon Reutrakul; Somnuek Sungkanuparph
Journal:  Curr Res Microb Sci       Date:  2022-05-31

Review 7.  Drug Discovery and Development of Novel Therapeutics for Inhibiting TMAO in Models of Atherosclerosis and Diabetes.

Authors:  Ian Steinke; Nila Ghanei; Manoj Govindarajulu; Sieun Yoo; Juming Zhong; Rajesh H Amin
Journal:  Front Physiol       Date:  2020-10-29       Impact factor: 4.566

8.  Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.

Authors:  Naijian Li; Zhouli Dai; Zhang Wang; Zhishan Deng; Jiahuan Zhang; Jinding Pu; Weitao Cao; Tianhui Pan; Yumin Zhou; Zhaowei Yang; Jing Li; Bing Li; Pixin Ran
Journal:  Respir Res       Date:  2021-10-25

Review 9.  Neonatal intestinal dysbiosis.

Authors:  Mark A Underwood; Sagori Mukhopadhyay; Satyan Lakshminrusimha; Charles L Bevins
Journal:  J Perinatol       Date:  2020-09-23       Impact factor: 3.225

10.  Associations Between Fruit Intake and Risk of Diabetes in the AusDiab Cohort.

Authors:  Nicola P Bondonno; Raymond J Davey; Kevin Murray; Simone Radavelli-Bagatini; Catherine P Bondonno; Lauren C Blekkenhorst; Marc Sim; Dianna J Magliano; Robin M Daly; Jonathan E Shaw; Joshua R Lewis; Jonathan M Hodgson
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.